News > J&J is right on track to launch its Covid-19 vaccine, says executive

J&J is right on track to launch its Covid-19 vaccine, says executive

Johnson & Johnson’s top executive said that the company is “comfortable” meeting its 2021 supply commitments for the Covid-19 vaccine. J&J is currently prepping for regulatory filings and formulating plans for the global rollout of its vaccine after publishing phase 3 trial results.

If the data are positive, that could meaningfully accelerate the rollout of vaccinations across the US and potentially disrupt other vaccine manufacturers’ demand expectations.